Objective to explore the related factors for severe ventricular arrhythmias during the early period after cardiac valve replacement.
目的探讨心脏瓣膜置换术后早期严重室性心律失常发生的相关因素。
Objective: To evaluate the efficacy and safety of ENCP in treating patients with severe slow cardiac arrhythmias.
目的：探讨体外无创性心脏起搏（ENCP）治疗严重过缓型心律失常的安全性和有效性。
Serious adverse events have included cardiac arrhythmias, thrombocytopenia, and severe hypersensitivity reactions; potentially serious interactions with other drugs can also occur.
严重的副反应包括心律失常、血小板减少和超敏反应等，而且可出现与其他药物的交叉反应。
应用推荐